1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Endometrial cancers

Pembrolizumab with platinum-based chemotherapy then pembrolizumab maintenance for treating primary advanced or recurrent endometrial cancer ID6381

In development [GID-TA11461] Expected publication date: 16 April 2025

  • Project information
  • Project documents

NIHRIO BN: 37144-Pembrolizumab-Chemotherapy-for-Endometrial-Cancer-V1.0-OCT2023-NON-CONF-.pdf (nihr.ac.uk)